SALUCK RANDY S. 4
4 · CLEVELAND BIOLABS INC · Filed May 10, 2013
Insider Transaction Report
Form 4
SALUCK RANDY S.
Director
Transactions
- Award
Stock Option (right to buy)
2013-05-08+15,000→ 15,000 totalExercise: $1.82Exp: 2023-05-07→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments beginning on May 8, 2014.